Alan J. Russell

CIK: 0001853529

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)15 (45.5%)

Position reduction

Option Exercises (M)13 (39.4%)

Derivative conversions

Awards (A)5 (15.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EWTX

Edgewise Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (33 total)

EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
65K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
390 shares at avg. $44.46$17K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Exercise(M)
Direct
5.8K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Exercise(M)
Direct
7K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
3.2K shares at avg. $43.68$141K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
2.3K shares at avg. $43.68$99K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
65K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Restricted Stock Units
Direct
32.5K shares-
EWTX
Edgewise Therapeutics, Inc.
Jul 1, 2026
Exercise(M)
Direct
130.4K shares at avg. $0.45$59K
EWTX
Edgewise Therapeutics, Inc.
Jul 1, 2026
Sale(S)
Direct
130.4K shares at avg. $39.41$5.1M
EWTX
Edgewise Therapeutics, Inc.
Jul 1, 2026
Exercise(M)
Direct
69.6K shares at avg. $0.18$13K
EWTX
Edgewise Therapeutics, Inc.
Jul 1, 2026
Sale(S)
Direct
69.6K shares at avg. $39.41$2.7M
EWTX
Edgewise Therapeutics, Inc.
Nov 12, 2025
Exercise(M)
Direct
100K shares at avg. $0.18$18K
EWTX
Edgewise Therapeutics, Inc.
Nov 12, 2025
Sale(S)
Direct
100K shares at avg. $21.12$2.1M
EWTX
Edgewise Therapeutics, Inc.
Aug 26, 2025
Exercise(M)
Direct
100K shares at avg. $0.18$18K
EWTX
Edgewise Therapeutics, Inc.
Aug 26, 2025
Sale(S)
Direct
100K shares at avg. $14.60$1.5M
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Sale(S)
Direct
1.9K shares at avg. $13.39$26K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Exercise(M)
Direct
5.8K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Award(A)
Stock Option (Right to Buy)
Direct
168.8K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Award(A)
Restricted Stock Units
Direct
28.1K shares-
EWTX
Edgewise Therapeutics, Inc.
May 2, 2025
Sale(S)
Direct
1.6K shares at avg. $16.45$26K
EWTX
Edgewise Therapeutics, Inc.
May 1, 2025
Exercise(M)
Direct
5.2K shares-
EWTX
Edgewise Therapeutics, Inc.
Mar 7, 2025
Sale(S)
Direct
200 shares at avg. $30.02$6K
EWTX
Edgewise Therapeutics, Inc.
Mar 7, 2025
Exercise(M)
Direct
200 shares at avg. $0.18$36
EWTX
Edgewise Therapeutics, Inc.
Feb 6, 2025
Exercise(M)
Direct
1.2K shares at avg. $0.18$216

		Type	Shares	Price		Ownership
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	65,000	-	-	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	390	$44.46	$17,339	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	5,781	-	$0	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	7,031	-	$0	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	3,238	$43.68	$141,428	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	2,273	$43.68	$99,275	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	65,000	-	-	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Restricted Stock Units	32,500	-	-	Direct
Jul 1, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	130,352	$0.45	$58,658	Direct
Jul 1, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	130,352	$39.41	$5,136,651	Direct
Jul 1, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	69,648	$0.18	$12,537	Direct
Jul 1, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	69,648	$39.41	$2,744,751	Direct
Nov 12, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	100,000	$0.18	$18,000	Direct
Nov 12, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	100,000	$21.12	$2,112,450	Direct
Aug 26, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	100,000	$0.18	$18,000	Direct
Aug 26, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	100,000	$14.60	$1,459,760	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	1,907	$13.39	$25,539	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	5,781	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	168,750	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Award(A) Restricted Stock Units	28,125	-	-	Direct
May 2, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	1,551	$16.45	$25,520	Direct
May 1, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	5,209	-	-	Direct
Mar 7, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	200	$30.02	$6,004	Direct
Mar 7, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	200	$0.18	$36	Direct
Feb 6, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	1,200	$0.18	$216	Direct

1-25 of 33 transactions

About Russell Alan J

Russell Alan J (SEC CIK 0001853529) files insider reports with the SEC as Chief Scientific Officer of Edgewise Therapeutics, Inc. (EWTX).

Signal8 holds 11 ownership filings by Russell Alan J, all Form 4s, filed between Sep 24, 2024 and Aug 17, 2026. Those filings report 33 transactions, from Sep 20, 2024 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Russell Alan J's filings is in BOULDER, CO.

Recent filings by Russell Alan J

Aug 12, 2026: Grant or award of EWTX derivative securities (Form 4, code A).
Aug 12, 2026: Open-market sale of EWTX shares (Form 4, code S).
Aug 12, 2026: Option exercises of EWTX shares (2 lines, Form 4, code M).
Aug 12, 2026: Open-market sales of EWTX shares (2 lines, Form 4, code S).
Aug 12, 2026: Grants or awards of EWTX derivative securities (2 lines, Form 4, code A).

Other insiders filing for Edgewise Therapeutics, Inc. (EWTX)

Fox Jonathan C, Director
Nofi Michael, Chief Financial Officer
Donovan Joanne M., CMO
MOORE JOHN R, General Counsel
Derakhshan Behrad, Chief Business Officer
KOCH KEVIN, President and CEO

How to read Form 4 transaction codes